SPBC3E7.17 Antibody

Shipped with Ice Packs
In Stock

Description

Molecular Target and Biological Context

The SPBC3E7.17 gene encodes Sup11p, a protein critical for cell viability in S. pombe. Sup11p is implicated in:

  • Cell wall integrity: Modulating β-1,3-glucan synthesis and cross-linking via glucanosyltransferases like Gas2p .

  • Septum formation: Regulating deposition of cell wall material during cytokinesis .

  • Protein glycosylation: Participating in O-mannosylation pathways, with hypo-mannosylated forms observed in mutant backgrounds .

Antibody Applications and Experimental Data

The SPBC3E7.17 antibody has been utilized in diverse experimental approaches:

ApplicationMethodKey Findings
Protein localizationImmunofluorescenceSup11p localizes to the septum and cell wall during cytokinesis .
Functional analysisGene deletion/complementationSPBC3E7.17 deletion causes lethal defects in septum separation .
Glycosylation studiesWestern blotSup11p exhibits hypo-mannosylation in O-mannosylation-deficient mutants .
Transcriptome profilingMicroarray analysisSup11p depletion upregulates glucanases (e.g., gas1+, gas2+) and cell wall remodeling genes .

Technical Advantages of SPBC3EAntibody

  • High specificity: Validated for Western blot, immunofluorescence, and proteinase K protection assays .

  • Quantitative reproducibility: Compatible with ratiometric assays (e.g., roGFP2) for redox studies .

  • Utility in systems biology: Enables transcriptome-wide analysis of cell wall stress responses .

Research Implications

  • Biomarker potential: Sup11p-regulated genes (e.g., gas2+) could serve as indicators of cell wall stress in fungal pathogens .

  • Therapeutic targeting: Insights into Sup11p’s role in glycosylation may inform antifungal drug development .

  • Evolutionary conservation: Homologs in pathogenic fungi (e.g., Candida albicans) suggest conserved roles in cell wall dynamics .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPBC3E7.17Putative uncharacterized protein C3E7.17 antibody
Target Names
SPBC3E7.17
Uniprot No.

Q&A

What is SPBC3E7.17 and why is it significant in fission yeast research?

SPBC3E7.17 is a protein found in Schizosaccharomyces pombe (fission yeast), a model organism widely used for studying fundamental cellular processes. Fission yeast serves as an excellent experimental system due to its genetic tractability and the conservation of many pathways between yeast and higher eukaryotes. The SPBC3E7.17 protein (UniProt Number: G2TRQ5) represents an important target for researchers exploring cellular mechanisms that may have parallels in human cells. Studying this protein contributes to our understanding of basic biological processes that may be relevant to human disease mechanisms .

What are the validated applications for the SPBC3E7.17 antibody?

The commercially available SPBC3E7.17 antibody has been validated for ELISA and Western Blot (WB) applications. These techniques enable researchers to detect and quantify the presence of SPBC3E7.17 protein in various experimental contexts, including protein expression studies, localization experiments, and comparative analyses across different genetic backgrounds or experimental conditions .

What are the key specifications of the available SPBC3E7.17 antibody?

SpecificationDetails
HostRabbit
ClonalityPolyclonal
ImmunogenRecombinant S. pombe (strain 972/ATCC 24843) SPBC3E7.17 protein
ApplicationsELISA, Western Blot
Storage-20°C or -80°C
Components200μg antigens (positive control), 1ml pre-immune serum (negative control), purified antibody
PurificationAntigen Affinity
Species ReactivityYeast

How should I optimize Western blot protocols for detecting SPBC3E7.17 in fission yeast extracts?

When optimizing Western blot protocols for SPBC3E7.17 detection, consider the following methodological approach:

  • Sample preparation: Extract proteins using either TCA precipitation or mechanical disruption with glass beads in buffer containing protease inhibitors to preserve protein integrity.

  • Controls: Utilize both the positive control (recombinant antigen) and negative control (pre-immune serum) provided with the antibody .

  • Antibody dilution: Begin with a 1:1000 dilution of the primary antibody and adjust based on signal strength and background.

  • Blocking optimization: Test different blocking agents (5% BSA vs. 5% non-fat milk) to minimize background.

  • Exposure times: For low-abundance proteins, consider longer exposure times or more sensitive detection methods.

Similar optimization approaches have been successfully used with other yeast proteins, as demonstrated in the fission yeast studies utilizing antibodies against proteins like Rhb1 .

What are the recommended cell lysis methods for SPBC3E7.17 extraction from S. pombe?

For optimal extraction of SPBC3E7.17 from S. pombe cells:

  • Mechanical disruption: Use glass beads with vortexing in extraction buffer (50mM Tris-HCl pH 7.5, 150mM NaCl, 0.1% NP-40, 1mM EDTA, protease inhibitor cocktail).

  • Enzymatic approach: For gentler extraction, treat cells with zymolyase (1mg/ml for 30 minutes at 30°C) to digest the cell wall before lysis.

  • TCA precipitation: For total protein extraction, precipitate with 20% TCA, which has proven effective in fission yeast studies examining proteins like Tsc1/2 and Rhb1 .

  • Buffer conditions: Include phosphatase inhibitors if studying potential phosphorylation states of SPBC3E7.17.

The choice of method should be based on the specific experimental goals and downstream applications.

How can I determine whether SPBC3E7.17 forms protein complexes in vivo?

To investigate protein complexes involving SPBC3E7.17:

  • Co-immunoprecipitation (Co-IP):

    • Use the SPBC3E7.17 antibody for immunoprecipitation from yeast lysates

    • Analyze precipitates for interacting partners by mass spectrometry or Western blotting

    • Include appropriate controls (pre-immune serum, unrelated antibodies)

  • Proximity Ligation Assay (PLA):

    • Combine SPBC3E7.17 antibody with antibodies against suspected interacting partners

    • Visualize interactions through fluorescence microscopy

  • Additional validation methods:

    • Cross-validate findings using tagged versions of SPBC3E7.17

    • Confirm interactions using yeast two-hybrid or split-GFP approaches

This approach mirrors successful methodologies used in fission yeast research examining protein interactions in the TSC pathway .

How can I distinguish between specific SPBC3E7.17 signal and non-specific binding in my experiments?

To differentiate specific signal from non-specific binding:

  • Control experiments:

    • Always include the pre-immune serum provided with the antibody as a negative control

    • If available, use SPBC3E7.17 deletion strains as additional negative controls

    • Perform peptide competition assays by pre-incubating the antibody with excess antigen

  • Signal validation:

    • Verify that the detected band matches the predicted molecular weight of SPBC3E7.17

    • Compare signal patterns in wild-type vs. mutant strains

    • Assess whether signal intensity correlates with expected expression under different conditions

  • Quantitative analysis:

    • Quantify signal-to-noise ratios under different experimental conditions

    • Compare the patterns observed with SPBC3E7.17 to those seen with well-characterized antibodies

Similar approaches have been used successfully for validating antibodies against fission yeast proteins like Rhb1 .

What are potential causes for inconsistent SPBC3E7.17 detection between experiments?

Inconsistent detection may result from:

  • Protein degradation: Ensure fresh protease inhibitors are used during extraction and sample preparation.

  • Antibody stability: Avoid repeated freeze-thaw cycles of the antibody; aliquot upon receipt.

  • Expression variations: Standardize growth conditions, as S. pombe protein expression can vary with growth phase and media conditions.

  • Technical variability: Maintain consistency in transfer conditions during Western blotting.

  • Post-translational modifications: Consider that modifications may affect epitope recognition.

  • Antibody lot variations: Polyclonal antibodies may show batch-to-batch variability; maintain reference samples for comparison .

How should I quantify SPBC3E7.17 expression levels accurately from immunoblot data?

For accurate quantification:

  • Normalization strategy:

    • Use appropriate loading controls (e.g., tubulin, actin) validated for fission yeast

    • Ensure signals fall within the linear range of detection

  • Technical considerations:

    • Perform at least three biological replicates

    • Use image analysis software that performs proper background subtraction

    • Include a dilution series of samples to verify the linear range of detection

  • Statistical analysis:

    • Apply appropriate statistical tests based on experimental design

    • Report data with standard deviation or standard error

    • Use non-parametric tests when appropriate for small sample sizes

These quantification approaches align with established practices in fission yeast research examining protein expression patterns .

How can I use the SPBC3E7.17 antibody to investigate changes in protein localization during cell cycle progression?

To study cell cycle-dependent localization:

  • Synchronization methods:

    • Use nitrogen starvation and release to synchronize S. pombe cells

    • Alternatively, utilize temperature-sensitive cdc mutants or elutriation

  • Immunofluorescence microscopy:

    • Fix cells at different cell cycle stages

    • Permeabilize and incubate with SPBC3E7.17 antibody followed by fluorescent secondary antibody

    • Co-stain with cell cycle markers (e.g., tubulin for mitotic spindle, DAPI for DNA)

  • Quantitative analysis:

    • Measure relative intensities in different cellular compartments

    • Track changes in localization patterns throughout the cell cycle

    • Apply statistical analysis to quantify significant changes

This approach has been used effectively to study protein localization changes in response to nitrogen starvation in fission yeast, as demonstrated in studies examining the TSC pathway .

How can I use the SPBC3E7.17 antibody to investigate post-translational modifications?

To study post-translational modifications:

  • Two-dimensional gel electrophoresis:

    • Separate proteins by isoelectric point and molecular weight

    • Detect SPBC3E7.17 using the antibody

    • Identify shifts indicating modifications

  • Modification-specific approaches:

    • Treat samples with phosphatase before Western blotting to identify phosphorylation

    • Use specific inhibitors to block modifications of interest

    • Examine modification patterns under different growth or stress conditions

  • Mass spectrometry integration:

    • Immunoprecipitate SPBC3E7.17 using the antibody

    • Perform MS analysis to identify specific modification sites

    • Compare modifications under different experimental conditions

This integrative approach has been successfully applied in fission yeast studies examining protein modifications in response to environmental changes .

How can I determine if SPBC3E7.17 expression is affected by nutrient availability or stress conditions?

To investigate regulation under different conditions:

  • Experimental design:

    • Expose S. pombe cultures to different stressors (oxidative stress, nutrient limitation, temperature)

    • Collect samples at defined time points

    • Extract proteins using consistent methodology

  • Expression analysis:

    • Perform Western blot using the SPBC3E7.17 antibody

    • Quantify relative expression levels normalized to appropriate controls

    • Compare expression patterns across conditions

  • Complementary approaches:

    • Integrate with transcriptional analysis (RT-qPCR or RNA-seq)

    • Consider chromatin immunoprecipitation to examine transcriptional regulation

    • Evaluate potential post-transcriptional regulation mechanisms

Studies in fission yeast have shown that nitrogen starvation significantly affects gene expression patterns, including genes involved in the TSC pathway, making this a relevant approach for studying SPBC3E7.17 regulation .

What are the most common technical challenges when using SPBC3E7.17 antibody and how can they be addressed?

Common challenges and solutions include:

  • High background in Western blots:

    • Increase blocking time or concentration

    • Use alternative blocking agents (BSA vs. milk)

    • Increase washing steps and duration

    • Reduce primary antibody concentration

  • No signal detected:

    • Verify protein expression under experimental conditions

    • Check for protein degradation during extraction

    • Consider epitope masking due to sample preparation

    • Evaluate alternative extraction methods

  • Multiple bands in Western blot:

    • Determine if bands represent degradation products, isoforms, or non-specific binding

    • Use deletion strains as negative controls

    • Perform peptide competition assays to identify specific bands

  • Variable results between experiments:

    • Standardize growth conditions and extraction protocols

    • Prepare larger antibody aliquots to reduce freeze-thaw cycles

    • Include consistent positive controls across experiments

How can I validate the specificity of the SPBC3E7.17 antibody in my experimental system?

Validation approaches include:

  • Genetic validation:

    • Compare results between wild-type and SPBC3E7.17 deletion strains

    • Use strains with tagged versions of SPBC3E7.17 (e.g., HA-tag) and detect with both anti-HA and anti-SPBC3E7.17

  • Biochemical validation:

    • Perform peptide competition assays using the provided antigen

    • Compare results with the pre-immune serum control provided with the antibody

    • Analyze whether signal corresponds to known expression patterns

  • Complementary approaches:

    • Compare results with alternative detection methods

    • Generate recombinant expression constructs for validation

    • Consider mass spectrometry confirmation of detected bands

Similar validation approaches have been used effectively for antibodies against fission yeast proteins, as demonstrated in the development of antibodies against proteins like Rhb1 .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.